Real-world evaluation of ceftolozane/tazobactam therapy and clinical outcomes in France-Reference-Cited by-同舟云学术

Real-world evaluation of ceftolozane/tazobactam therapy and clinical outcomes in France

Published:2021-09 Issue:6 Volume:51 Page:532-539
ISSN:2666-9919
Container-title:Infectious Diseases Now
language:en
Short-container-title:Infectious Diseases Now

Author:

Castan Bernard,Akrich Brune,Levy-Bachelot Laurie,Amode Anna^ORCID,Berthelot Anne,Mackosso Carole,Mathis Lucie,Mootien Joy,Ruimy Raymond,Ruiz Fabrice^ORCID,Timsit Jean-François,Boutoille D.

Funder

MSD France

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference19 articles.

1. Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis;Watkins;Expert Rev Anti Infect Ther,2013

2. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms;Jacobson;Clin Infect Dis,1995

3. In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae;Titelman;Diagn Microbiol Infect Dis,2011

4. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012);Sader;J Infect,2014

5. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI);Solomkin;Clin Infect Dis,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftolozane/Tazobactam for the Treatment of Adults With Cystic Fibrosis: Results From a French Prospective Cohort Study;Open Forum Infectious Diseases;2024-07-30

2. Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings—A French Real-world Study;Open Forum Infectious Diseases;2024-02-01

3. Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients;Annals of Intensive Care;2023-07-18

4. Surveillance of the Impact of Antimicrobial Resistant infections in Immunosuppressed Children’s therapy: A systematic review;2023-04-14

5. The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies;Expert Review of Anti-infective Therapy;2023-01-19